Submit a proposal
…down the “CTRL” button while clicking on the additional beamline. Please use this multi-select function when applying for Beamtime. Once you click “Save & Continue” or “Save & Return…
…down the “CTRL” button while clicking on the additional beamline. Please use this multi-select function when applying for Beamtime. Once you click “Save & Continue” or “Save & Return…
…can apply for an access card to MAX IV premises All participants in the session get access to the experimental data All samples & substances you plan to use for…
…IV collaborates with various consortium and projects through which users can apply for “privileged beamtime” access, read more about beamtime collaborations and how to apply here: Collaborations offering beamtime chevron_right…
There is consensus among physicists that strict parity selectivity is required in dipole approximation with soft X-rays in the field of resonant inelastic X-ray scattering (RIXS). Meaning, when photons hit…
X‐ray imaging approaching the low nanometer range is one of the most rapidly and strongly developing areas at all modern synchrotrons, e.g., ESRF, PETRA III, APS, Soleil or NSLS II….
…about conditions for purchasing your own place. Information about schools and pre-schools including applications, the Swedish queue system, as well as help contacting schools and setting up visits. Orientation about…
Photon energy 30 – 1500 eV Polarizations Linear horizontal Linear vertical (energy minimum approx. 45 eV) Circular (under commissioning) Resolving power Typically about 5000 (at 400 eV). Under special circumstances…
…from call closure, until a final result is approved by MAX IV management, and the decisions are sent out to all applicants. 0. Communicate with beamline staff Discuss the planned experiment…
…these vacancies may appear in a great variety of different motifs. This makes borophene a highly polymorphic material. An extra charge transfer to or from the borophene (e.g. via the…
…how long protection lasts with vaccination, the appearance of new virus variants, and a lack of existing, effective drugs against Covid-19, have increased the urgency for development of targeted, SARS-CoV-2…